1-3 of 3
Kathrin Seidemann
Close
Sort by
Journal Articles

The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95

Clinical Trials & Observations
Wilhelm Woessmann, Kathrin Seidemann, Georg Mann, Martin Zimmermann, Birgit Burkhardt, Ilske Oschlies, Wolf-Dieter Ludwig, Thomas Klingebiel, Norbert Graf, Bernd Gruhn, Heribert Juergens, Felix Niggli, Reza Parwaresch, Helmut Gadner, Hansjoerg Riehm, Martin Schrappe, Alfred Reiter, for the BFM Group
Journal: Blood
Blood (2005) 105 (3): 948–958.
https://doi.org/10.1182/blood-2004-03-0973
Published: 2005
Journal Articles

Methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and risk of pediatric non-Hodgkin lymphoma in a German study population

Martin Stanulla, Kathrin Seidemann, Eckart Schnakenberg, Marion Book, Andrea Mehles, Karl Welte, Martin Schrappe, Alfred Reiter
Journal: Blood
Blood (2005) 105 (2): 906–907.
https://doi.org/10.1182/blood-2004-09-3550
Published: 2005
Journal Articles

Short-pulse B–non-Hodgkin lymphoma–type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Clinical Trials & Observations
Kathrin Seidemann, Markus Tiemann, Martin Schrappe, Elif Yakisan, Ingrid Simonitsch, Gritta Janka-Schaub, Wolfgang Dörffel, Martin Zimmermann, Georg Mann, Helmut Gadner, Reza Parwaresch, Hansjörg Riehm, Alfred Reiter
Journal: Blood
Blood (2001) 97 (12): 3699–3706.
https://doi.org/10.1182/blood.V97.12.3699
Published: 2001